Approval · Notice of Compliance 28942 · 2022
BOTOX: Notice of Compliance 28942
Issued September 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28942
- Date
- September 9, 2022
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOTOX | 01981501 | Marketed |
| BOTOX | Not yet assigned | — |
Medicinal ingredients
- ONABOTULINUMTOXINA 100 UNIT per VIAL
- ONABOTULINUMTOXINA 50 UNIT per VIAL
- ONABOTULINUMTOXINA 200 UNIT per VIAL